Evaluation of Ceftriaxone Plus Avibactam in an Intracellular Hollow Fiber Model of Tuberculosis: Implications for the Treatment of Disseminated and Meningeal Tuberculosis in Children

BACKGROUND: Ceftazidime-avibactam is an effective agent for the treatment of tuberculosis (TB) but requires frequent administration because of a short half-life. Due to a longer half-life, ceftriaxone could allow intermittent dosing. METHODS: First, we identified the MIC of ceftriaxone with 15 mg/L...

Descripción completa

Detalles Bibliográficos
Autores principales: Srivastava, Shashikant, van Zyl, Johanna, Cirrincione, Kayle, Martin, Katherine, Thomas, Tania, Deshpande, Devyani, Alffenaar, Jan-William, Seddon, James A., Gumbo, Tawanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Antimicrobial Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654946/
https://www.ncbi.nlm.nih.gov/pubmed/32773662
http://dx.doi.org/10.1097/INF.0000000000002857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654946/
https://www.ncbi.nlm.nih.gov/pubmed/32773662
http://dx.doi.org/10.1097/INF.0000000000002857

Ejemplares similares